Placebo-controlled trial of flosequinan in moderate heart failure. The possible importance of aetiology and method of analysis in the interpretation of the results of heart failure trials
- 28 February 1993
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 38 (2) , 167-175
- https://doi.org/10.1016/0167-5273(93)90176-h
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failureJournal of the American College of Cardiology, 1989
- Effect of flosequinan on exercise capacity and symptoms in severe heart failure.Heart, 1989
- Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.BMJ, 1988
- Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart FailureJAMA, 1988
- Mortality in heart failure: clinical variables of prognostic value.Heart, 1987
- SYMPTOMATIC ASSESSMENT OF PATIENTS WITH HEART FAILURE: DOUBLE-BLIND COMPARISON OF INCREASING DOSES OF DIURETICS AND CAPTOPRIL IN MODERATE HEART FAILUREThe Lancet, 1986
- Six minute walking test for assessing exercise capacity in chronic heart failure.BMJ, 1986
- Designs for group sequential testsControlled Clinical Trials, 1984
- Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1983
- Perceived exertion as an indicator of somatic stressJournal of Rehabilitation Medicine, 1970